regulatory
confidence high
sentiment negative
materiality 0.65
Lunai Bioworks Inc. (LNAI): Nasdaq/NYSE listing notice — Renovaro receives Nasdaq deficiency notice for low bid price; 180-day cure period
Lunai Bioworks Inc.
- Notice dated April 14, 2025 for failure to maintain $1 minimum bid price over 30 consecutive business days.
- Initial compliance period ends October 13, 2025; must close at $1.00 for 10 consecutive days.
- If not cured, may qualify for second 180-day period if meeting other listing standards.
- Stock continues trading under symbol RENB; Company evaluating options to regain compliance.